Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 250

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites

Zhao, Mei, Sano, Daisuke, Pickering, Curtis R., Jasser, Samar A., Henderson, Ying C., Clayman, Gary L., Sturgis, Erich M., Ow, Thomas J., Lotan, Reuben, Carey, Thomas E., Sacks, Peter G., Grandis, Jennifer R., Sidransky, David, Heldin, Nils Erik, Myers, Jeffrey N.·2011·Clinical Cancer Research

Published version of a preprint

Abstract

Purpose: Human cell lines are useful for studying cancer biology and preclinically modeling cancer therapy, but can be misidentified and cross-contamination is unfortunately common. The purpose of this study was to develop a panel of validated head and neck cell lines representing the spectrum of tissue sites and histologies that could be used for studying the molecular, genetic, and phenotypic diversity of head and neck cancer. Methods: A panel of 122 clinically and phenotypically diverse head and neck cell lines from head and neck squamous cell carcinoma, thyroid cancer, cutaneous squamous cell carcinoma, adenoid cystic carcinoma, oral leukoplakia, immortalized primary keratinocytes, and normal epithelium was assembled from the collections of several individuals and institutions. Authenticity was verified by carrying out short tandem repeat analysis. Human papillomavirus (HPV) status and cell morphology were also determined. Results: Eighty-five of the 122 cell lines had unique genetic profiles. HPV-16 DNA was detected in 2 cell lines. These 85 cell lines included cell lines from the major head and neck primary tumor sites, and close examination shows a wide range of in vitro phenotypes. Conclusions: This panel of 85 genomically validated head and neck cell lines represents a valuable resource for the head and neck cancer research community that can help advance understanding of the disease by providing a standard reference for cell lines that can be used for biological as well as preclinical studies. Clin Cancer Res; 17(23); 7248–64. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-11-0690

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 21

  1. Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 · DOI
  2. Carvalho, 2005, Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database, Int J Cancer, 114, 806, 10.1002/ijc.20740 · DOI
  3. Ansari, 2007, Salivary gland tumors in an Iranian population: a retrospective study of 130 cases, J Oral Maxillofac Surg, 65, 2187, 10.1016/j.joms.2006.11.025 · DOI
  4. Monks, 1991, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J Natl Cancer Inst, 83, 757, 10.1093/jnci/83.11.757 · DOI
  5. Dirks, 2004, Authentication of cancer cell lines by DNA fingerprinting, Methods Mol Med, 88, 43
  6. Lin, 2007, Head and neck squamous cell carcinoma cell lines: established models and rationale for selection, Head Neck, 29, 163, 10.1002/hed.20478 · DOI
  7. Masters, 2001, Short tandem repeat profiling provides an international reference standard for human cell lines, Proc Natl Acad Sci U S A, 98, 8012, 10.1073/pnas.121616198 · DOI · Paper page
  8. Park, 1991, Immortalization of normal human oral keratinocytes with type 16 human papillomavirus, Carcinogenesis, 12, 1627, 10.1093/carcin/12.9.1627 · DOI
  9. Min, 1994, Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines, Eur J Cancer B Oral Oncol, 30B, 338, 10.1016/0964-1955(94)90036-1 · DOI
  10. Gupta, 2009, Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT, Int J Radiat Oncol Biol Phys, 74, 928, 10.1016/j.ijrobp.2009.03.004 · DOI
  11. Chen, 1997, Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences, Cancer Res, 57, 1614
  12. Langendijk, 2010, The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies, Ann Oncol, 21, 1931, 10.1093/annonc/mdq439 · DOI
  13. Lorenzi, 2009, DNA fingerprinting of the NCI-60 cell line panel, Mol Cancer Ther, 8, 713, 10.1158/1535-7163.MCT-08-0921 · DOI · Paper page
  14. Giard, 1973, In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors, J Natl Cancer Inst, 51, 1417, 10.1093/jnci/51.5.1417 · DOI
  15. Sturgis, 2007, Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?, Cancer, 110, 1429, 10.1002/cncr.22963 · DOI
  16. Marur, 2010, HPV-associated head and neck cancer: a virus-related cancer epidemic, Lancet Oncol, 11, 781, 10.1016/S1470-2045(10)70017-6 · DOI
  17. Ang, 2010, Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, 363, 24, 10.1056/NEJMoa0912217 · DOI
  18. D'Souza, 2007, Case-control study of human papillomavirus and oropharyngeal cancer, N Engl J Med, 356, 1944, 10.1056/NEJMoa065497 · DOI
  19. Poeta, 2007, TP53 mutations and survival in squamous-cell carcinoma of the head and neck, N Engl J Med, 357, 2552, 10.1056/NEJMoa073770 · DOI
  20. 2011, Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer, Clin Cancer Res, 17, 6658, 10.1158/1078-0432.CCR-11-0046 · DOI
  21. Yang, 2007, Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer, Oncogene, 26, 1459, 10.1038/sj.onc.1209929 · DOI

Cited by

See all 250

Metadata

Authors
Zhao, M., Sano, D., Pickering, C. R., Jasser, S. A., Henderson, Y. C., Clayman, G. L., Sturgis, E. M., Ow, T. J., Lotan, R., Carey, T. E., Sacks, P. G., Grandis, J. R., Sidransky, D., Heldin, N. E., & Myers, J. N.
Affiliations
Authors' Affiliations: Departments of 1Head and Neck Surgery and 2Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 3Department of Otolaryngology, University of Michigan Medical School, Ann Arbor, Michigan; 4Department of Basic Science and Craniofacial Biology, College of Dentistry, New York University, New York, New York; 5Department of Otolaryngology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; 6Department of Otolaryngology, Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and 7Department of Pathology, University of Uppsala, Uppsala, Sweden
Venue
Clinical Cancer Research
Published
2011-11-30
Volume
17
Issue
23
Pages
7248-7264
ISSN
  • 1078-0432
  • 1557-3265
Cited by
250
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-11-0690
The paper
Zhao, M., Sano, D., Pickering, C. R., Jasser, S. A., Henderson, Y. C., Clayman, G. L., Sturgis, E. M., Ow, T. J., Lotan, R., Carey, T. E., Sacks, P. G., Grandis, J. R., Sidransky, D., Heldin, N. E., & Myers, J. N. (2011). Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-0690